IID has received its impact factor!
Impact factor: 2.5
2019 Journal Citation Reports (Clarivate Analytics): 112/158 (Immunology)
Many thanks to all authors for the trust and reviewers for their vital work.
Nouvelle publication du Dr Stéphanie Pons sur la thématique de l'immunomodulation par les cellules endothéliales dans le cadre du sepsis.
Bravo !
https://t.co/6DKfvKxi7C
@ImmunityAnd@SFAR_ORG@La_SRLF@APHP
📢Thanks to @iuis_online for providing registration grants to attend the @2021ECI ! To be in with a chance of getting waived registration:
1. Submit an abstract by May 24
🔗https://t.co/Yu1usGaat5
2. Apply for a grant @EFIS_Immunology
🔗https://t.co/N4P5zHrVc8
Publishing #openaccess can broaden the impact of your work, but did you know you might be able to publish #OA in Immunity, Inflammation and Disease at no direct cost? Check to see if you’re eligible. https://t.co/9EMfgaIk2d
@wileyinresearch
Check out our latest paper showing #GCSF is not pathogenic (and maybe protective?) in #lupus published in Immunity, Inflammation and Disease @ImmunityAnd https://t.co/EcStFAihep
Do review please. You may learn something new, ensure quality and robustness in your field. But be on time.
Support your field. If nobody is willing to review, nothing will be published and the field will be poorer for it.
Don´t expect others to do the reviewing, if you don´t.
Remember as authors; choose your potential reviewer carefully: not your friends nor those that are unlikely to look at your manuscript.
Add as many potential reviewers to Manuscript central. All scientists are busy and may not have time when you submit an manuscript.
Lots of authors are publishing #openaccess in Immunity, Inflammation and Disease at no direct cost. @wileyinresearch has #OA agreements with many countries and regions. Check to see if you're eligible. https://t.co/9EMfgaIk2d
Publishing #openaccess can broaden the impact of your work, but did you know you might be able to publish #OA in Immunity, Inflammation and Disease at no direct cost? Check to see if you’re eligible. https://t.co/9EMfgaIk2d @wileyinresearch
Good news! You may be able to publish #openaccess in Immunity, Inflammation and Disease at no direct cost. @wileyinresearch has agreements with many countries and regions. Check if you’re eligible.
https://t.co/9EMfgaIk2d
IL-6 signaling requires only few interleukin-6 molecules: Relation to physiological concentrations of extracellular IL-6.
Understand what a given plasma concentration of a cytokine signifies. Out in IID soon!
@Morten_Bagge
Excellent new paper accepted.
In biopsies, upregulation of DNASE1L3 in asthma and IL1B in neutrophilic asthma similar to previously findings in sputum.
Coming online soon on https://t.co/o6sfplPpy2
@SSanchezOvando